To explore the molecular mechanism of the tumor suppressive function of CLDN7 in ccRCC, GSEA was performed to evaluate the different gene expression profiles between low- and high-CLDN7 expression groups of ccRCC patients. The gene discussed is CLDN7; the disease is nonpapillary renal cell carcinoma.